Summary
Sixty patients with ANLL were given intensified remission induction therapy consisting of thioguanine, cytosine arabinoside and daunorubicin (TAD). The mean age of patients was 47.6 years (range 18 to 74 years). Basing on leukemic cell kinetic data time sequencing of drugs was different from the original TAD protocol. Complete remission (CR) was achieved in 43/60 patients (72%) with 10 CR in 15 patients over 60 years of age. Seventy-nine percent of the CR were induced by one cycle vs. thirty percent reported from the original TAD regimen. The major cause of induction failure — in ten of the 60 patients — was thrombocytopenia refractory to platelet transfusions. Persisting leukemia after two induction cycles was documented in only two patients. Median remission duration by life table analysis is 10 months with 17 patients in continuous CR for 1+ to 22+ months.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Büchner T, Göhde W, Schumann J, Barlogie B (1976) In vivo kinetic response of human leukemia cells to antileukemic drugs as seen in the DNA histogram. In: Proc 16th Intern Congr Hematol, Kyoto. Excerpta Med Int Congr Ser 415: 265–269
Büchner T, Urbanitz D, Hiddemann W, Kamanabroo D, Meister R, Balleisen L, Delvos U, Lagreze EM, Schmitz-Huebner U, Schulte H, van de Loo J (1979) Intensification of remission induction therapy for acute nonlymphocytic leukemia (ANLL). Blut 39: 133–140
Gale RP, Cline MJ (1977) High remission-induction rate in acute myeloid leukemia. Lancet I: 497–499
Peterson BA, Bloomfield CD, Bosl GJ, Gibbs G, Malloy M (1980) Intensive five-drug combination chemotherapy for adult acute nonlymphocytic leukemia. Cancer 46: 663–668
Preissler HD, Rustum Y, Henderson ES, Bjornsson S, Creaven PJ, Higby DJ, Freeman A, Gailani S, Naeher C (1979) Treatment of acute nonlymphocytic leukemia: Use of anthracycline-cytosine arabinoside induction therapy and comparison of two maintenance regimens. Blood 53: 454–464
Rees JKH, Sandler RM, Challener J, Hayhoe FGJ (1977) Treatment of acute myeloid leukaemia with a triple cytotoxic regime: DAT. Br J Cancer 36: 770–776
Weinstein HJ, Mayer RJ, Rosenthal DS, Camitta BM, Coral FS, Nathan DG, Frei III E (1980) Treatment of acute myelogeneous leukemia in children and adults. N Engl J Med 303: 473–478
Author information
Authors and Affiliations
Additional information
Supported by a grant (BU 210/7) of the Deutsche Forschungsgemeinschaft
Rights and permissions
About this article
Cite this article
Urbanitz, D., Büchner, T., Kamanabroo, D. et al. Intensified remission induction therapy for acute nonlymphocytic leukemia (ANLL) treatment report on 60 patients. Blut 43, 129–133 (1981). https://doi.org/10.1007/BF00320474
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00320474